High-grade B-cell Non-hodgkin Lymphoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2026-03-05
Clinical Trial Update: Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) for the Treatment of Intermediate or High Grade B-Cell Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial evaluating CMV-specific CD19-CAR T-cells in combination with the CMV-MVA Triplex vaccine for intermediate- or high-…